Burns J W & Co. Inc. NY Sells 196 Shares of CME Group Inc. (NASDAQ:CME)

Burns J W & Co. Inc. NY lowered its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 1.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,827 shares of the financial services provider’s stock after selling 196 shares during the period. Burns J W & Co. Inc. NY’s holdings in CME Group were worth $2,979,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Franklin Resources Inc. grew its position in shares of CME Group by 70.4% in the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock valued at $544,157,000 after purchasing an additional 1,003,119 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock valued at $1,038,676,000 after buying an additional 537,758 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in shares of CME Group by 21,465.5% in the third quarter. International Assets Investment Management LLC now owns 485,871 shares of the financial services provider’s stock worth $1,072,070,000 after buying an additional 483,618 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of CME Group by 17.8% in the third quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after acquiring an additional 380,071 shares during the period. Finally, Baillie Gifford & Co. purchased a new position in CME Group during the third quarter valued at approximately $79,692,000. Institutional investors own 87.75% of the company’s stock.

Insider Activity at CME Group

In related news, insider Sunil Cutinho sold 4,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the transaction, the insider now directly owns 27,053 shares of the company’s stock, valued at approximately $6,131,291.92. This represents a 14.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 7,274 shares of company stock valued at $1,648,071 in the last 90 days. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Up 0.1 %

Shares of CME Group stock traded up $0.25 during midday trading on Monday, reaching $229.45. 1,644,939 shares of the company’s stock traded hands, compared to its average volume of 2,092,562. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $249.02. The company has a market cap of $82.69 billion, a PE ratio of 24.13, a price-to-earnings-growth ratio of 5.41 and a beta of 0.56. The stock has a 50 day moving average of $232.56 and a 200-day moving average of $218.87. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $2.25 earnings per share. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group declared that its board has authorized a stock repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its shares are undervalued.

CME Group Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, January 16th. Investors of record on Friday, December 27th will be paid a $5.80 dividend. The ex-dividend date is Friday, December 27th. This is an increase from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio is presently 48.37%.

Wall Street Analyst Weigh In

CME has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. Bank of America lifted their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Oppenheimer lifted their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. Keefe, Bruyette & Woods decreased their price target on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a report on Monday. Finally, TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $229.27.

Check Out Our Latest Research Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.